Collective Expert Perspectives on the Use of Safinamide as Adjunctive Therapy for Parkinson's Disease: Online-Based Delphi Survey

BACKGROUND: Safinamide is a selective, reversible monoamine oxidase-B inhibitor with a sodium channel inhibitory effect. Published clinical evidence supports safinamide as an effective therapy for Parkinson's disease (PD) with wearing-off. However, to date, no consensus recommendations have bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Atsushi, Tsuboi, Yoshio, Nomoto, Masahiro, Mochizuki, Hideki, Hattori, Nobutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307399/
https://www.ncbi.nlm.nih.gov/pubmed/35873701
http://dx.doi.org/10.1155/2022/3203212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307399/
https://www.ncbi.nlm.nih.gov/pubmed/35873701
http://dx.doi.org/10.1155/2022/3203212

Ejemplares similares